SUMMIT PARTNERS L P Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000830588

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q2 2026 · 5 positions · Total reported value $608.92M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 40.0% · 0 new · 2 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, SUMMIT PARTNERS L P disclosed 5 equity positions with a combined reported value of $608.92M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were KVYO ($284.68M), LFST ($249.65M), AKA ($64.84M). By sector, the heaviest allocations are Technology 47.1%, Health Care 41.0%. Versus the prior quarter, allocation shifted toward Health Care (+8.0pp), Consumer Discretionary (+1.3pp) and away from Other (-0.6pp), Technology (-9.3pp).

Versus the prior quarter, SUMMIT PARTNERS L P opened 0 new positions, trimmed 2 and fully exited 0, a turnover rate of 40.0% of positions. The portfolio's overlap with the prior quarter was 71% of names.

Of the 2 positions fully exited versus the prior quarter, the largest were AVAH ($35.08M), SBDS ($4.14M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

No new positions this quarter.

Fully Exited (vs previous quarter)

  • AVAH AVEANNA HEALTHCARE HLDGS INC · prev qtr: $35.08M
  • SBDS SOLO BRANDS INC COM CL A NEW · prev qtr: $4.14M

Insider Transactions (Form 4)

Latest SUMMIT PARTNERS L P buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-11 Sell Klaviyo, Inc. 5,000,000 $17.71 SEC filing
2026-08-11 Conversion Klaviyo, Inc. 5,000,000 — SEC filing

All insider transactions →

Fund Profile

Summit Partners is a Boston-based private equity and venture capital firm founded in 1984, focusing on growth equity, venture capital, and private equity investments across various sectors.

Investment Approach

Focuses on growth equity, venture capital, and private equity

Typically invests in companies with strong growth potential

Provides both capital and strategic guidance to portfolio companies

Asset Classes & Strategy

Growth equity: investments in established companies seeking capital for expansion

Venture capital: early-stage investments in innovative companies

Private equity: control investments in mature companies

Sectors include technology, healthcare, financial services, and more

Notable Facts

Founded in 1984

Has invested in over 500 companies

Known for partnering with management teams to drive growth

Maintains a global presence with offices in North America, Europe, and Asia

Key People

Robert C. Pozen: Chairman

Michael A. Cline: Co-CEO

Michael S. Goldstein: Co-CEO

This profile is based on publicly available information; please refer to official SEC filings for the most current and accurate data.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a cautious stance with a slight bias towards technology and health care sectors. The reduction in LIFESTANCE HEALTH GROUP INC suggests a potential concern about the health care sector, while the hold and slight increase in KLAVIYO INC indicates confidence in the technology sector. 2. Key Moves: - Added/Reduced: The fund did not add any new positions but reduced its stake in LIFESTANCE HEALTH GROUP INC significantly and slightly reduced its position in MACOM TECH SOLUTIONS HLDGS I. - By How Much: The reduction in LIFESTANCE HEALTH GROUP INC was substantial, down 20.2% quarter-over-quarter. MACOM TECH SOLUTIONS HLDGS I saw a significant reduction of 87.8% in shares held. 3. Portfolio Structure: - Passive/Active: The fund seems to be more passive, as it did not add new positions and maintained its existing holdings. - Sector Bias: The portfolio is biased towards technology and health care, with KLAVIYO INC and LIFESTANCE HEALTH GROUP INC being the largest holdings. - Risk Appetite: The risk appetite is moderate, with a focus on established companies in the technology and health care sectors. 4. Per-Holding One-Liner: - KVYO (KLAVIYO INC): A technology company specializing in AI-powered search and personalization solutions for e-commerce platforms. 'Verified' - LFST (LIFESTANCE HEALTH GROUP INC): A company that provides health care services, including home health care, hospice, and palliative care. 'Verified' - AKA (A K A BRANDS HLDG CORP): A consumer discretionary company focused on fashion accessories and apparel. 'Verified' - ATEN (A10 NETWORKS INC COM): A company that provides networking and communication solutions, including network switches and routers. 'Verified' - MTSI (MACOM TECH SOLUTIONS HLDGS I): A technology company that designs and manufactures high-performance analog and mixed-signal semiconductors. 'Verified' 5. One-Sentence Style Summary: The SUMMIT PARTNERS L P fund maintained a cautious, technology-focused stance, reducing exposure to the health care sector and holding steady in established technology companies.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Technology 47.1%
Health Care 41.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 18.85M $284.68M 46.75%
46.75%
Hold
2 23.31M $249.65M 41.00%
41.00%
Reduce
3 6.05M $64.84M 10.65%
10.65%
Hold
4 200.06K $7.47M 1.23%
1.23%
Hold
5 6.00K $2.28M 0.38%
0.38%
Reduce

FAQ

What did SUMMIT PARTNERS L P buy in 2026-Q2?

In its 2026-Q2 13F filing, SUMMIT PARTNERS L P reported 5 equity positions worth $608.92M in aggregate; its largest disclosed positions were KVYO ($284.68M), LFST ($249.65M), AKA ($64.84M).

How large is SUMMIT PARTNERS L P's portfolio?

SUMMIT PARTNERS L P reported $608.92M of long equity holdings across 5 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is SUMMIT PARTNERS L P's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/summit-partners-l-p/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →